“We treat until it’s gone.” Professor Marcus Maurer is joined by Professor Gordon Sussman to discuss the use of antihistamines in people with urticaria, covering the history, side effects, safety and best practices.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links and access additional resources relating to the topics discussed in this episode: Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials and Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria.
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
Read more news regarding urticaria
Journal Club,News
April 22, 2024Join us on Thursday, May 2 from 12.00 to 12.45 pm CET, for the UCARE LevelUP Journal Club! Zhuoran Li (IFA Berlin) will speak about “DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis” [...]
Journal Club
April 19, 2024Join us on Thursday, May 16 from 12.00 to 12.45 pm CET, for the UCARE LevelUP Journal Club! Nian Liu (IFA Berlin) will speak on “TET2 regulates immune tolerance in chronically activated mast cells” [...]
New centers,News
April 19, 2024On March 26, 2024, we welcomed Servidor Público Estadual de São Paulo Hospital, HSPE-SP Allergy Division in São Paulo, Brazil to the UCARE network. Head: Prof. Fátima Rodrigues Fernandes Deputy: Dr. Maria Elisa [...]